Journal
CANCER CELL INTERNATIONAL
Volume 21, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12935-021-02309-9
Keywords
Synthetic derivatives; Breast cancer cell line; MDR breast cancer cell line; Cytotoxicity
Categories
Ask authors/readers for more resources
Cancer is the second leading cause of death worldwide, with breast cancer being the most deadly among women. The increasing mutation and resistance of breast cancer cells are leading to a growing death rate, emphasizing the need for new therapeutic compounds and treatment methods. Synthetic compounds show promise in enhancing cytotoxicity towards breast cancer cells and may play a vital role in overcoming drug resistance.
Cancer is the second most killer worldwide causing millions of people to lose their lives every year. In the case of women, breast cancer takes away the highest proportion of mortality rate than other cancers. Due to the mutation and resistance-building capacity of different breast cancer cell lines against conventional therapies, this death rate is on the verge of growth. New effective therapeutic compounds and treatment method is the best way to look out for in this critical time. For instance, new synthetic derivatives/ analogues synthesized from different compounds can be a ray of hope. Numerous synthetic compounds have been seen enhancing the apoptosis and autophagic pathway that directly exerts cytotoxicity towards different breast cancer cell lines. To cease the ever-growing resistance of multi-drug resistant cells against anti-breast cancer drugs (Doxorubicin, verapamil, tamoxifen) synthetic compounds may play a vital role by increasing effectivity, showing synergistic action. Many recent and previous studies have reported that synthetic derivatives hold potentials as an effective anti-breast cancer agent as they show great cytotoxicity towards cancer cells, thus can be used even vastly in the future in the field of breast cancer treatment. This review aims to identify the anti-breast cancer properties of several synthetic derivatives against different breast cancer and multi-drug-resistant breast cancer cell lines with their reported mechanism of action and effectivity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available